June 8, 2005 — The U.S. Food and Drug Administration (FDA) approved in March revisions to safety labeling to advise that use of rosuvastatin calcium tablets is associated with an increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback